Johnson & Johnson and Alpine Immune Sciences, Inc.: SG&A Spending Patterns Compared

SG&A Spending Patterns: A Tale of Two Companies

In the world of corporate finance, Selling, General, and Administrative (SG&A) expenses are a crucial indicator of a company's operational efficiency. Over the past decade, Johnson & Johnson and Alpine Immune Sciences, Inc. have exhibited contrasting SG&A spending patterns.

Johnson & Johnson: A Steady Giant

From 2014 to 2023, Johnson & Johnson's SG&A expenses have remained relatively stable, averaging around $21 billion annually. This consistency reflects the company's robust operational framework and its ability to maintain efficiency despite market fluctuations.

Alpine Immune Sciences: A Growth Story

In contrast, Alpine Immune Sciences has seen a dramatic increase in SG&A expenses, growing nearly tenfold from 2014 to 2023. This surge underscores the company's aggressive expansion strategy and its commitment to scaling operations.

These spending patterns highlight the diverse strategies employed by companies in managing their operational costs, offering valuable insights for investors and analysts alike.